23-09-2026 09:43
via
bakeryandsnacks.com
Are GLP-1s creating Big Food’s next valuation trap?
GLP-1 drugs are influencing food M&A, but buyers risk overvaluing health-led assets and underpricing adaptable bakery and snack businesses.
Read more »
Food news
The rise of private label functional foods
Toblerone Biscoff and the trends transforming confectionery
Sweeteners and the microbiome: What do we know?
Do consumers actually like pumpkin spice?
Hershey bets a ‘little extra’ can make candy feel like more as it courts premium shoppers
From Mars to Ferrero: Confectionery bets big on ultra-premium chocolate
UPF meta-analysis lands as industry debates definitions
CP Foods taps protein boom with chicken and egg push
East or West? Tips for brands to strategise food export growth
The EUDR must go ahead or risk losing credibility
Mondelēz makes Toblerone Pink Crush permanent in major first
FDA’s GRAS overhaul could add pressure to agency – can AI help?
5 ways GLP-1s are reshaping how consumers eat
Restaurants recovering from sales slump with CPG brands
Desktop versie